Methods of detecting early renal disease in animals
View Patent ↗The present invention provides a method for the detection of early renal disease in animals. The method includes the steps of (a) obtaining a sample from an animal to be tested and (b) determining the amount of albumin in the sample. An amount of albumin in the range of from 10 μg/ml to about 300 μg/ml indicates the presence of early renal disease. The present invention also provides antibodies to canine, feline and equine albumin which can be used to detect the presence of early renal disease.
1. A method to detect early renal disease in a canid, a feud or an equid comprising:
(a) obtaining a urine sample from said canid, feud or equid; and
(b) determining the amount of albumin in said sample,
wherein an amount of albumin in a range from about 10 μg/ml to about 300 μg/ml in the sample, when the specific gravity of the sample is normalized to 1.010, is indicative of early renal disease.
2. The method of claim 1 , wherein the method is repeated at least once.
3. The method of claim 1 , wherein the method is repeated at least once to monitor a disease or the effect of a therapy.
4. The method of claim 1 , wherein the method is performed once.
5. The method of claim 1 , wherein the determination of the amount of albumin in the sample is performed at room temperature.
6. The method of claim 1 , wherein the amount of albumin in the sample is determined by:
(a) contacting the sample with an albumin-binding compound to form an albumin-compound complex;
(b) detecting the albumin-compound complex; and
(c) assessing the amount of albumin present in the sample from the amount of albumin-compound complex detected.
7. The method of claim 6 , wherein the albumin-binding compound is an anti-albumin antibody.
8. The method of claim 6 , wherein the albumin-binding compound is an anti-albumin antibody which recognizes albumin from an animal selected from the group consisting of canids, felids and equids.
9. The method of claim 1 , wherein the amount of albumin in the sample is determined using an assay selected from the group consisting of an enzyme-linked immunoassay, a radioimmunoassay, a fluorescence immunoassay, a chemiluminescent assay, a lateral-flow assay, a dipstick assay, an agglutination assay, a particulate-based assay, an immunoprecipitation assay, an immunodot assay, an immunoblot assay, an immunodiffusion assay, a phosphorescence assay, a flow-through assay, a chromatography assay, a PAGe-based assay, an electronic-sensory assay, a surface plasmon resonance assay and a fluorescence correlation spectroscopy assay.
10. The method of claim 1 , wherein the amount of albumin in the sample is determined using an enzyme-linked immunosorbent assay (ELISA).
11. The method of claim 1 , wherein the amount of albumin in the sample is determined using a single-step assay.
12. The method of claim 1 , wherein the amount of albumin in the sample is determined using a dipstick-based assay.
13. The method of claim 1 , wherein the amount of albumin is determined using an assay that detects albumin in the sample when the amount of albumin is in a range from about 10 μg/ml to about 50 μg/ml when the specific gravity of the sample is normalized to 1.010.
14. The method of claim 1 , wherein the amount of albumin is determined using an assay that detects albumin in the sample when the amount of albumin is about 50 μg/ml when the specific gravity of the sample is normalized to 1.010.
15. The method of claim 1 , wherein the amount of albumin is determined using an assay that detects albumin in the sample when the amount of albumin is about 25 μg/ml when the specific gravity of the sample is normalized to 1.010.
16. The method of claim 1 , wherein the amount of albumin is determined using an assay that detects albumin in the sample when the amount of albumin is about 10 μg/ml when the specific gravity of the sample is normalized to 1.010.
17. The method of claim 1 , wherein the urine sample is obtained from a canid.
18. The method of claim 1 , wherein the urine sample is obtained from a felid.
19. The method of claim 1 , wherein the urine sample is obtained from an equid.
20. The method of claim 1 , wherein the sample is pre-treated prior to determining the amount of albumin.
21. The method of claim 1 , wherein the sample is pre-treated by adjusting the specific gravity.
22. The method of claim 1 , wherein the sample is pre-treated by adjusting the specific gravity to 1.010.
23. A method to identify a canid, a felid or an equid at risk for developing late-stage renal disease comprising:
(a) obtaining a urine sample from said canid, felid or equid; and
(b) determining the amount of albumin in said sample,
wherein an amount of albumin in a range from about 10 μg/ml to about 300 μg/ml in the sample, when the specific gravity of the sample is normalized to 1.010, indicates the animal is at risk for late-stage renal disease.
24. The method of claim 23 , wherein the method is repeated at least once.
25. The method of claim 23 , wherein the method is repeated at least once to monitor a disease or the effect of a therapy.
26. The method of claim 23 , wherein the method is performed once.
27. The method of claim 23 , wherein the determination of the amount of albumin in the sample is performed at room temperature.
28. The method of claim 23 , wherein the amount of albumin in the sample is determined by:
(a) contacting the sample with an albumin-binding compound to form an albumin-compound complex;
(b) detecting the albumin-compound complex; and
(c) assessing the amount of albumin present in the sample from the amount of albumin-compound complex detected.
29. The method of claim 28 , wherein the albumin-binding compound is an anti-albumin antibody.
30. The method of claim 28 , wherein the albumin-binding compound is an anti-albumin antibody which recognizes albumin from an animal selected from the group consisting of canids, feuds and equids.
31. The method of claim 23 , wherein the amount of albumin in the sample is determined using an assay selected from the group consisting of an enzyme-linked immunoassay, a radioimmunoassay, a fluorescence immunoassay, a chemiluminescent assay, a lateral-flow assay, a dipstick assay, an agglutination assay, a particulate-based assay, an immunoprecipitation assay, an immunodot assay, an immunoblot assay, an immunodiffusion assay, a phosphorescence assay, a flow-through assay, a chromatography assay, a PAGe-based assay, an electronic-sensory assay, a surface plasmon resonance assay and a fluorescence correlation spectroscopy assay.
32. The method of claim 23 , wherein the amount of albumin in the sample is determined using an enzyme-linked immunosorbent assay (ELISA).
33. The method of claim 23 , wherein the amount of albumin in the sample is determined using a single-step assay.
34. The method of claim 23 , wherein the amount of albumin in the sample is determined using a dipstick-based assay.
35. The method of claim 23 , wherein the amount of albumin is determined using an assay that detects albumin in the sample when the amount of albumin is in a range from about 10 μg/ml to about 50 μg/ml when the specific gravity of the sample is normalized to 1.010.
36. The method of claim 23 , wherein the amount of albumin is determined using an assay that detects albumin in the sample when the amount of albumin is about 50 μg/ml when the specific gravity of the sample is normalized to 1.010.
37. The method of claim 23 , wherein the amount of albumin is determined using an assay that detects albumin in the sample when the amount of albumin is about 25 μg/ml when the specific gravity of the sample is normalized to 1.010.
38. The method of claim 23 , wherein the amount of albumin is determined using an assay that detects albumin in the sample when the amount of albumin is about 10 μg/ml when the specific gravity of the sample is normalized to 1.010.
39. The method of claim 23 , wherein the urine sample is obtained from a felid.
40. The method of claim 23 , wherein the urine sample is obtained from an equid.
41. The method of claim 23 , wherein the urine sample is obtained from a canid.